SPL 2.11% 9.3¢ starpharma holdings limited

Ann: AstraZeneca presents 1st DEP candidate as Bcl2/xL inhibitor, page-79

  1. 4,870 Posts.
    lightbulb Created with Sketch. 259
    Well not everybody is up to that Sarge and people can make awful decisions doing that if they don't have the skill or nouse so OK for you and OK for me but you know some need advice hopefully they pick the right adviser.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.